Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,744 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mortality, left ventricular ejection fraction, and prevalence of new left ventricular wall motion abnormality at long-term follow-up in patients with implantable cardioverter defibrillators treated with biventricular pacing versus right ventricular pacing.
Sukhija R, Aronow WS, Sorbera C, Peterson SJ, Frishman WH, Cohen M. Sukhija R, et al. Among authors: cohen m. Am J Ther. 2007 Jul-Aug;14(4):328-30. doi: 10.1097/01.mjt.0000209686.44948.e8. Am J Ther. 2007. PMID: 17667205
Patients, mean age 70 years, with automatic implantable cardioverter-defibrillators treated with dual-chamber rate responsive pacing (DDDR-70) have a higher mortality than patients with backup ventricular pacing (VVI-40) at 3.7-year follow-up.
Sukhija R, Aronow WS, Sorbera C, Yalamanchili K, Cohen M. Sukhija R, et al. Among authors: cohen m. J Gerontol A Biol Sci Med Sci. 2005 May;60(5):603-4. doi: 10.1093/gerona/60.5.603. J Gerontol A Biol Sci Med Sci. 2005. PMID: 15972611
Left ventricular ejection fraction and prevalence of new left ventricular wall motion abnormality at long-term follow-up in patients with automatic implantable cardioverter-defibrillators treated with dual-chamber rate-responsive pacing at a rate of 70/minute versus backup ventricular pacing at a rate of 40/minute.
Sukhija R, Aronow WS, Sorbera C, Kakar P, Peterson SJ, Frishman WH, Cohen M. Sukhija R, et al. Among authors: cohen m. Am J Cardiol. 2005 Aug 1;96(3):412-3. doi: 10.1016/j.amjcard.2005.03.088. Am J Cardiol. 2005. PMID: 16054470
Statins reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapy.
Desai H, Aronow WS, Tsai FS, Ahn C, Lai HM, Amin H, Gandhi K, Frishman WH, Cohen M, Sorbera C. Desai H, et al. Among authors: cohen m. J Cardiovasc Pharmacol Ther. 2009 Sep;14(3):176-9. doi: 10.1177/1074248409340157. Epub 2009 Jul 17. J Cardiovasc Pharmacol Ther. 2009. PMID: 19617418
Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure treated with combined cardiac resynchronization plus implantable cardioverter-defibrillator therapy versus implantable cardioverter-defibrillator therapy.
Desai H, Aronow WS, Ahn C, Tsai FS, Lai HM, Gandhi K, Amin H, Frishman WH, Kalapatapu K, Cohen M, Sorbera C. Desai H, et al. Among authors: cohen m. J Cardiovasc Pharmacol Ther. 2010 Mar;15(1):37-40. doi: 10.1177/1074248409351408. Epub 2009 Dec 4. J Cardiovasc Pharmacol Ther. 2010. PMID: 19966176
12,744 results
You have reached the last available page of results. Please see the User Guide for more information.